These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12955216)
1. [Volumetric MRI for evaluation of regional pattern and progressin of neocortical degeneration in Alzheimer's disease]. Leinsinger G; Teipel S; Wismüller A; Born C; Meindl T; Flatz W; Schönberg S; Pruessner J; Hampel H; Reiser M Radiologe; 2003 Jul; 43(7):537-42. PubMed ID: 12955216 [TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472 [TBL] [Abstract][Full Text] [Related]
3. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Teipel SJ; Bayer W; Alexander GE; Bokde AL; Zebuhr Y; Teichberg D; Müller-Spahn F; Schapiro MB; Möller HJ; Rapoport SI; Hampel H Neurobiol Aging; 2003; 24(1):85-94. PubMed ID: 12493554 [TBL] [Abstract][Full Text] [Related]
4. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Teipel SJ; Hampel H; Pietrini P; Alexander GE; Horwitz B; Daley E; Möller HJ; Schapiro MB; Rapoport SI Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337 [TBL] [Abstract][Full Text] [Related]
5. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment. Wang H; Su MY Dement Geriatr Cogn Disord; 2006; 22(3):223-9. PubMed ID: 16900000 [TBL] [Abstract][Full Text] [Related]
6. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies. Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753 [TBL] [Abstract][Full Text] [Related]
7. Progression of corpus callosum atrophy in Alzheimer disease. Teipel SJ; Bayer W; Alexander GE; Zebuhr Y; Teichberg D; Kulic L; Schapiro MB; Möller HJ; Rapoport SI; Hampel H Arch Neurol; 2002 Feb; 59(2):243-8. PubMed ID: 11843695 [TBL] [Abstract][Full Text] [Related]
8. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Chaim TM; Duran FL; Uchida RR; Périco CA; de Castro CC; Busatto GF Psychiatry Res; 2007 Jan; 154(1):59-68. PubMed ID: 17174533 [TBL] [Abstract][Full Text] [Related]
9. Progression of corpus callosum atrophy in early stage of Alzheimer's disease: MRI based study. Zhu M; Gao W; Wang X; Shi C; Lin Z Acad Radiol; 2012 May; 19(5):512-7. PubMed ID: 22342652 [TBL] [Abstract][Full Text] [Related]
10. Corpus callosum atrophy and cognitive decline in early Alzheimer's disease: longitudinal MRI study. Zhu M; Wang X; Gao W; Shi C; Ge H; Shen H; Lin Z Dement Geriatr Cogn Disord; 2014; 37(3-4):214-22. PubMed ID: 24193144 [TBL] [Abstract][Full Text] [Related]
11. Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. Lyoo IK; Satlin A; Lee CK; Renshaw PF Psychiatry Res; 1997 May; 74(2):63-72. PubMed ID: 9204509 [TBL] [Abstract][Full Text] [Related]
12. Evidence for atrophy of the corpus callosum in Alzheimer's disease. Vermersch P; Scheltens P; Barkhof F; Steinling M; Leys D Eur Neurol; 1994; 34(2):83-6. PubMed ID: 8174599 [TBL] [Abstract][Full Text] [Related]
13. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease. Horínek D; Varjassyová A; Hort J Curr Opin Psychiatry; 2007 May; 20(3):273-7. PubMed ID: 17415082 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease. Kabay SC; Gulbandilar E; Ozden H; Ozbag D; Guven G; Adapinar B; Durmaz R Neurodegener Dis; 2009; 6(4):148-53. PubMed ID: 19521062 [TBL] [Abstract][Full Text] [Related]
17. White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy. Vermersch P; Roche J; Hamon M; Daems-Monpeurt C; Pruvo JP; Dewailly P; Petit H J Neurol; 1996 Mar; 243(3):231-4. PubMed ID: 8936352 [TBL] [Abstract][Full Text] [Related]
18. [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex]. Möller T; Born C; Reiser MF; Möller HJ; Hampel H; Teipel SJ Nervenarzt; 2009 Jan; 80(1):54-61. PubMed ID: 18810380 [TBL] [Abstract][Full Text] [Related]
19. Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease. Elahi S; Bachman AH; Lee SH; Sidtis JJ; Ardekani BA; J Alzheimers Dis; 2015; 45(3):921-31. PubMed ID: 25633676 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Efficacy of Structural MRI in Patients With Mild-to-Moderate Alzheimer Disease: Automated Volumetric Assessment Versus Visual Assessment. Min J; Moon WJ; Jeon JY; Choi JW; Moon YS; Han SH AJR Am J Roentgenol; 2017 Mar; 208(3):617-623. PubMed ID: 28075620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]